Researchers for the ongoing 30-year Diabetes Prevention Program found out last week that the NIH canceled funding for the project. (Independent)
Gender-affirming hormone therapy was associated with a lower risk of moderate-to-severe depressive symptoms in transgender adults, an observational cohort study suggested. (JAMA Network Open)
The VA announced plans to phase out gender-affirming healthcare for veterans.
A small randomized trial showed that obeticholic acid (Ocaliva), a farnesoid X receptor agonist, significantly reduced liver fat among patients with familial partial lipodystrophy. (Journal of Clinical Endocrinology & Metabolism)
A Polish study presented at this year's European Congress on Obesity found that marriage triples the risk of obesity for men but not women. (The Guardian)
CVS Health became the first U.S. company to receive the Menopause Friendly Accreditation.
A cross-sectional study of healthy postmenopausal women showed that three U.S. Preventive Services Task Force-recommended osteoporosis risk assessment tools had fair-to-moderate discrimination in identifying lowest bone mineral density at a skeletal site. (JAMA Network Open)
Ten weeks of water aerobics helped adults with overweight or obesity significantly reduce their weight and waist circumference, according to a meta-analysis. (BMJ Open)
Sleeping 6 or fewer hours a night with occasional or regular snoring was tied to an increased risk of type 2 diabetes among women with a history of gestational diabetes, a cohort study showed. (JAMA Network Open)
Entera Bio and OPKO Health announced a partnership to develop the first oral dual agonist GLP-1/glucagon peptide as a once-daily treatment for patients with obesity and metabolic and fibrotic disorders.
A Mendelian randomization study found a causal relationship between thyroid function and multiple sclerosis. (Scientific Reports)
Data from the Study of Women's Health Across the Nation showed that abnormal uterine bleeding during the menopause transition was associated with symptoms of fatigue. (Menopause)
author['full_name']
Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.